|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMSP0505AE06
|
type II B antigen(d18:1/26:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc-Fuc-Cer 44:1;O2
|
C82H150N2O32
|
1675.017178
|
|
LMSP0505AF02
|
type II A antigen(d18:1/18:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C76H137N3O32
|
1603.918527
|
|
LMSP0505AF04
|
type II A antigen(d18:1/22:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C80H145N3O32
|
1659.981127
|
|
LMSP0505AF06
|
type II A antigen(d18:1/26:0)
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C84H153N3O32
|
1716.043727
|
|
LMSP0505AF08
|
type II A antigen(d18:1/26:1(17Z))
|
GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C84H151N3O32
|
1714.028077
|
|
LMSP0505AG03
|
Ley-6(d18:1/20:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 38:1;O2
|
C76H138N2O31
|
1574.928363
|
|
LMSP0505AG04
|
Ley-6(d18:1/22:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 40:1;O2
|
C78H142N2O31
|
1602.959663
|
|
LMSP0505AG06
|
Ley-6(d18:1/26:0)
|
Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc-Fuc(2)-Cer 44:1;O2
|
C82H150N2O31
|
1659.022263
|
|
LMSP0505AH03
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C84H151N3O37
|
1794.002652
|
|
LMSP0505AH04
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C86H155N3O37
|
1822.033952
|
|
LMSP0505AH07
|
|
Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C88H157N3O37
|
1848.049602
|
|
LMSP0505AI04
|
type III H antigen(d18:1/22:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 40:1;O2
|
C92H165N3O41
|
1968.091862
|
|
LMSP0505AI05
|
type III H antigen(d18:1/24:0)
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 42:1;O2
|
C94H169N3O41
|
1996.123162
|
|
LMSP0505AI08
|
type III H antigen(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 44:2;O2
|
C96H171N3O41
|
2022.138812
|
|
LMSP0505AJ04
|
type III A antigen(d18:1/22:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 40:1;O2
|
C100H178N4O46
|
2171.171236
|
|
LMSP0505AK02
|
nLc5Cer(d18:1/18:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc(2)-Cer 36:1;O2
|
C70H127N3O28
|
1457.860617
|
|
LMSP0505AK03
|
nLc5Cer(d18:1/20:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc(2)-Cer 38:1;O2
|
C72H131N3O28
|
1485.891917
|
|
LMSP0505AK04
|
nLc5Cer(d18:1/22:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc(2)-Cer 40:1;O2
|
C74H135N3O28
|
1513.923217
|
|
LMSP0505AK05
|
nLc5Cer(d18:1/24:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc(2)-Cer 42:1;O2
|
C76H139N3O28
|
1541.954517
|
|
LMSP0505AK08
|
nLc5Cer(d18:1/26:1(17Z))
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc(2)-Cer 44:2;O2
|
C78H141N3O28
|
1567.970167
|
|
LMSP0505AL02
|
nLc6Cer(d18:1/18:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Cer 36:1;O2
|
C76H137N3O33
|
1619.913442
|
|
LMSP0505AL03
|
nLc6Cer(d18:1/20:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Cer 38:1;O2
|
C78H141N3O33
|
1647.944742
|
|
LMSP0505AL04
|
nLc6Cer(d18:1/22:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Cer 40:1;O2
|
C80H145N3O33
|
1675.976042
|
|
LMSP0505AL06
|
nLc6Cer(d18:1/26:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Cer 44:1;O2
|
C84H153N3O33
|
1732.038642
|
|
LMSP0505AM01
|
type II H antigen(d18:1/16:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C80H143N3O37
|
1737.940052
|
|
LMSP0505AM02
|
type II H antigen(d18:1/18:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C82H147N3O37
|
1765.971352
|
|
LMSP0505AM04
|
type II H antigen(d18:1/22:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C86H155N3O37
|
1822.033952
|
|
LMSP0505AM06
|
type II H antigen(d18:1/26:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C90H163N3O37
|
1878.096552
|
|
LMSP0505AM08
|
type II H antigen(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C90H161N3O37
|
1876.080902
|
|
LMSP0505AN03
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(3)-Cer 38:1;O2
|
C86H154N4O38
|
1851.024116
|
|
LMSP0505AN04
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(3)-Cer 40:1;O2
|
C88H158N4O38
|
1879.055416
|
|
LMSP0505AN05
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(3)-Cer 42:1;O2
|
C90H162N4O38
|
1907.086716
|
|
LMSP0505AN06
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(3)-Cer 44:1;O2
|
C92H166N4O38
|
1935.118016
|
|
LMSP0505AN07
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(3)-Cer 42:2;O2
|
C90H160N4O38
|
1905.071066
|
|
LMSP0505AN08
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(3)-Cer 44:2;O2
|
C92H164N4O38
|
1933.102366
|
|
LMSP0505AO04
|
type II B antigen(d18:1/22:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C92H165N3O42
|
1984.086777
|
|
LMSP0505AO05
|
type II B antigen(d18:1/24:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C94H169N3O42
|
2012.118077
|
|
LMSP0505AO07
|
type II B antigen(d18:1/24:1(15Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(5)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C94H167N3O42
|
2010.102427
|
|
LMSP0505AP02
|
I antigen(d18:1/18:0)
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(5)-HexNAc(3)-Cer 36:1;O2
|
C90H160N4O43
|
1985.045641
|
|
LMSP0505AP03
|
I antigen(d18:1/20:0)
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(5)-HexNAc(3)-Cer 38:1;O2
|
C92H164N4O43
|
2013.076941
|
|
LMSP0505AP04
|
I antigen(d18:1/22:0)
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(5)-HexNAc(3)-Cer 40:1;O2
|
C94H168N4O43
|
2041.108241
|
|
LMSP0505AP05
|
I antigen(d18:1/24:0)
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(5)-HexNAc(3)-Cer 42:1;O2
|
C96H172N4O43
|
2069.139541
|
|
LMSP0505AP06
|
I antigen(d18:1/26:0)
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(5)-HexNAc(3)-Cer 44:1;O2
|
C98H176N4O43
|
2097.170841
|
|
LMSP0505AP07
|
I antigen(d18:1/24:1(15Z))
|
Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(5)-HexNAc(3)-Cer 42:2;O2
|
C96H170N4O43
|
2067.123891
|
|
LMSP0505AQ03
|
type II A antigen(d18:1/20:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(3)-Fuc-Cer 38:1;O2
|
C92H164N4O42
|
1997.082026
|
|
LMSP0505AQ04
|
type II A antigen(d18:1/22:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(3)-Fuc-Cer 40:1;O2
|
C94H168N4O42
|
2025.113326
|
|
LMSP0505AQ06
|
type II A antigen(d18:1/26:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(3)-Fuc-Cer 44:1;O2
|
C98H176N4O42
|
2081.175926
|
|
LMSP0505AQ07
|
type II A antigen(d18:1/24:1(15Z))
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(3)-Fuc-Cer 42:2;O2
|
C96H170N4O42
|
2051.128976
|
|
LMSP0505AR02
|
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(5)-HexNAc(3)-Fuc(2)-Cer 36:1;O2
|
C102H180N4O51
|
2277.161461
|
|
LMSP0505AR05
|
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(5)-HexNAc(3)-Fuc(2)-Cer 42:1;O2
|
C108H192N4O51
|
2361.255361
|